Core Points - The company has nominated Ms. Wang Zhiyao as an independent non-executive director candidate for the 11th Board of Directors, pending approval at the shareholders' meeting [1] - Ms. Wang has completed the required independent director training and obtained the necessary certification recognized by the Shenzhen Stock Exchange [2] - The qualifications and independence of the independent director candidate have been reviewed and approved by the Shenzhen Stock Exchange without any objections [2] Summary by Sections - Nomination of Independent Director: The company held a board meeting on November 10, 2025, where it approved the nomination of Ms. Wang Zhiyao as an independent non-executive director candidate, subject to shareholder approval [1] - Training Certification: As of the date of the first extraordinary shareholders' meeting notification, Ms. Wang had not yet obtained the independent director training certification. However, she has since completed the training and received the certification [2] - Regulatory Compliance: The independent director candidate's qualifications and independence have been filed and reviewed by the Shenzhen Stock Exchange, confirming no issues [2]
丽珠医药集团股份有限公司 关于独立董事候选人取得独立董事 培训证明的公告